Clinical Trial Update: The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC. [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating SHR-1316 with chemoradiotherapy in small-cell lung cancer is ongoing; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• SHR-1316

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Small-cell Lung Cancer | Phase 3 | Status: UNKNOWN